ENTERO Vu 24%
These highlights do not include all the information needed to use ENTERO VU 24% safely and effectively. See full prescribing information for ENTERO VU 24%. ENTERO VU 24% (barium sulfate) oral suspension Initial U.S. Approval: 2016
83a06a8e-93db-a59b-933c-5882127bce7c
HUMAN PRESCRIPTION DRUG LABEL
Jan 17, 2022
E-Z-EM Canada Inc
DUNS: 204211163
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
barium sulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
barium sulfate
Product Details
FDA regulatory identification and product classification information
